Welcome to the SITC Researcher Resource page, a collection of resources for researchers from the experts in cancer immunotherapy.The resources here are specifically curated for researchers and provide foundational knowledge about tumor immunology and cancer immunotherapy, education on practical application of cancer immunotherapy and access to the latest in basic, translational and clinical research.
Programs and publications are developed to empower early career scientists with the tumor immunology and cancer immunotherapy basics to take their careers and research to the next level.
Featured Resource: Cancer Immunotherapy Winter School A comprehensive education program covering the fundamentals of cancer immunotherapy
These programs and publications provide scientists at all levels with the tools to successfully conduct cancer immunotherapy research and inspire new research pathways.
Featured Resource: Topic-driven WorkshopsLearn about the hot topics in the field of cancer immunotherapy through SITC's topic-driven workshops
This content is for scientists looking to keep up to date with the latest developments in cancer immunotherapy or for ways to share knowledge with others in the field.
Featured Resource: SITC's Annual Meeting & Pre-Conference ProgramsDiscover the latest developments in the field at the largest conference focused solely on cancer immunotherapy
Live Webinar Series: SITC-NCI Computational Immuno-OncologyIn partnership with the National Cancer Institute (NCI), the Society for Immunotherapy of Cancer (SITC) is pleased to launch a new series of nine computational immuno-oncology webinars. These free-to-attend digital events will help individual research labs to embrace the computational challenges of analyzing and integrating diverse assay data across the spectrum of immuno-oncology.
VIEW ALL RESOURCES
Live Webinar Series: Targets for Cancer Immunotherapy: A Deep Dive Webinar SeriesEach of the eight seminars will feature leaders in the immuno-oncology field who are experts in a given subject area to provide an overview of the current scientific knowledge about a therapy. An interactive Q&A session will follow the topic overview, providing participants with the opportunity to ask in-depth questions of the faculty as well as offering a forum for networking and initiation of collaborations with others working in a similar field.Related seminar series topics:
Publication: Journal for ImmunoTherapy of CancerThe Journal for ImmunoTherapy of Cancer, the official journal of the Society for Immunotherapy of Cancer (SITC), is an open access, peer-reviewed journal with a 2020 impact factor of 13.751.
Position article and guidelines: "Society for Immunotherapy of Cancer clinical and biomarkers data sharing resource document: Volume II—practical challenges"
Position article and guidelines: “Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of lymphoma"Position article and guidelines: "Defining current gaps in quality measures for cancer immunotherapy: consensus report from the Society for Immunotherapy of Cancer (SITC) 2019 Quality Summit"
Hybrid Event: 36th Annual Meeting & Pre-Conference ProgramsNovember 10-14, 2021 • Washington, D.C. • Join us in person or virtuallyJoin SITC in Washington, D.C., or virtually, Nov. 10-14, 2021, to take part in the leading destination for scientific exchange, education and networking in the cancer immunotherapy field.
Publication and Live Webinar Series: SITC Cancer Immunotherapy Guidelines: Immune Checkpoint Inhibitor-related Adverse EventsThe SITC Cancer Immunotherapy Guidelines Webinars connect clinicians with leading experts in the field and provide education about the evidence- and consensus-based recommendations in the Clinical Practice Guidelines.Publication: Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immune checkpoint inhibitor-related adverse eventsOn-Demand Webinars: Click here to watch all three webinar recordings
On-Demand: Targets for Cancer Immunotherapy: A Deep Dive Seminar SeriesThis eight-part seminar series features leaders in the immuno-oncology field who are experts in a given subject area to provide an overview of the current scientific knowledge about a therapy. An interactive Q&A session will follow the topic overview, providing participants with the opportunity to ask in-depth questions of the faculty as well as offering a forum for networking and initiation of collaborations with others working in a similar field.As permitted by the presenters, on-demand presentations (slides and recorded video) are available for purchase for non-registrants at fifty percent of the registration rate. You can select access by seminar or for the full series.
Event: 2021 Sparkathon Accelerator: Emerging Leader Igniting InnovationNovember 9-10, 2021 • Washington, D.C. This two-year program will kick off prior to SITC 2021, in Washington, D.C. Sparkathon Class of 2021 participants will present their research on this year’s chosen topic of mechanisms of resistance to peers and luminaries in this area of the field. Participants will learn from each other and receive guidance from the experts in a synergistic and intimate environment.
This symposium will explore the preclinical and clinical data on sequencing of immunotherapies, in order to improve patient outcomes and ensure the field of immunotherapy remains at the forefront of oncology care.
Publication: Journal for ImmunoTherapy of CancerThe Journal for ImmunoTherapy of Cancer, the official journal of the Society for Immunotherapy of Cancer (SITC), is an open access, peer-reviewed journal with a 2020 impact factor of 13.751.Original Research: "Lung metastases share common immune features regardless of primary tumor origin"
Original Research: "Low-dose radiation treatment enhances systemic antitumor immune responses by overcoming the inhibitory stroma"
Original Research: "2,5-dimethylcelecoxib improves immune microenvironment of hepatocellular carcinoma by promoting ubiquitination of HBx-induced PD-L1"
Tel: +1 414 271 2456 | Fax: +1 414 276 3349 | Email: firstname.lastname@example.org